VIRTUAL SIMULATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION Jenna Smetana and Jessica Sider, Swanson School of Engineering THE TAVI PROCEDURE IS FEASIBLE.

Slides:



Advertisements
Similar presentations
ARTreat Vision. Atherosclerosis The problem Definition: “Atherosclerosis is a vascular disease associated with the accumulation of lipids leading to the.
Advertisements

Pinhas (Peter) Dartal 01 June QA role in development of Percutaneous Aortic Valve prosthesis.
Trileaflet Aortic Valve. Management strategy for patients with chronic severe aortic regurgitation. Preoperative coronary angiography should be performed.
THE USE OF A TRANSCATHETER AORTIC VALVE TO REPLACE A DEFECTIVE AORTIC VALVE WITHOUT OPEN-HEART SURGERY Natalie Garda and Adam Cotter Heart disease is the.
ACC 2015 Michael J Reardon, MD, FACC On Behalf of the CoreValve US Investigators A Randomized Comparison of Self-expanding Transcatheter and Surgical Aortic.
Implantable Cardioverter Defibrillator Rebecca Boduch Biomedical Engineering University of Rhode Island.
Congenital Heart Defects. Eight out of every 1,000 infants have some type of structural heart abnormality at birth. Such abnormalities, known as congenital.
PICO Question In patients over the age of 65 with symptomatic aortic stenosis, will standard aortic valve replacement or transcatheter aortic valve replacement.
Brain Scan Imaging MRI, CAT, PET Imaging Interpreting Functions of the Brain through Imaging – Activity Case Study – Professional Sports and Head Trauma.
Arrhythmia Treatment …which you researched! Coronary Artery Bypass Surgery Angioplasty Valve Replacement Aneurysm Repair Transplant.
Computer Science AND DOCTORS Jolena Co Truong- 6 th period.
 The vectorcardiograph (VCG) examines the ECG potentials generated along the three-dimensional axes of the body; that is, the x, y, and z planes.  The.
INTRODUCTION A 35 year old woman with transposition of the great arteries repaired with a Mustard procedure attends your clinic for annual follow-up. Her.
TAVR Pearls Addressing the Shortcomings of the Current TAVR Generation
Cardiovascular Unit (Day 4) Bell Ringer:  On a piece of paper, write your name and today’s date  Do not use your notes!!!  Write the process of how.
Exercise Management Aneurysms Chapter 16. Exercise Management Pathophysiology Aneurysms can be caused by congenital or acquired diseases, are usually.
Trans-catheter Aortic Valve Replacement: a UK update. Dr Martyn Thomas Guys and St Thomas’ Hospital.
Life-saving test picks up baby heart defects. Pulse Oximetry Pulse Oximetry involves clipping a sensor to a finger or foot and measuring how light is.
A shifting paradigm of care: Advances in transcatheter heart valve procedures Sandra Lauck MSN, RN, CCN(C) Clinical Nurse Specialist, Arrhythmia Management.
PARTNER Objective To compare surgical aortic valve replacement (AVR) with transcatheter aortic valve replacement (TAVR) in high-risk patients with severe.
DOCTOR BY BENNY SEGALL AND TOR CONEY. JULIET SMITH-KLINE Juliet is currently suffering from Blue Baby Syndrome, which is no longer a serious illness among.
Vanessa Beretta & Dan Fleming. About CHD A congenital heart defect also known as CHD is a defect in the structure of the heart and great vessels. Most.
© 2012 EuroIntervention. All rights reserved. EuroIntervention 2009;5: A comparison of patient characteristics and 30-day mortality outcomes after.
THE CARDIOVASCULAR SYSTEM BY: ALEX HOLT. MAJOR COMPONENTS THE CARDIOVASCULAR SYSTEM HEART BLOOD VESSELS BLOOD.
Aortic Valve Peravalvular Leak. Risk factors for Aortic Valve Peravalvular Leak u Endocarditis u calcified annulus u bicuspid aortic valve –Note many.
Randomized Trial of Ea rly S urgery Versus Conventional Treatment for Infective E ndocarditis (EASE) Duk-Hyun Kang, MD, PhD on behalf of The EASE Trial.
Senior MESA Day.  Application of engineering technology to fields of medicine and biology.  Combines design and problem solving skills of engineering.
Parametric Study of Mechanical Stress in Abdominal Aortic Aneurysms (AAA) Erin A. Lennartz Virginia Polytechnic Institute and State University Research.
Percutaneous Establishment of Tricuspid Regurgitation: An Experimental Model for Transcatheter Tricuspid Valve Replacement Yuan Bai, Gang-jun Zong, Yong-wen.
Trancatheter Aortic Valve Implantation (TAVI)
Functions of the Heart By Oliver Tang.
By Tyra Whye, Graham Rubin, and Noah Kaplan DOCTOR!
Heart Presentation Michele Lin Blk.: D. B l o o d F l o w.
Date of download: 5/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Transcatheter Valve-in-Valve and Valve-in-Ring for.
Causes of Heart Valve Dysfunction Congenital defects (bicuspid aortic valve) Infections (rheumatic fever and bacterial endocarditis Coronary artery disease.
CFD characterization and thrombogenicity analysis of a prototypal polymeric aortic valve Filippo Piatti 1, Matteo Selmi 1, Alessandra Pelosi 1, Thomas.
EXPANDING INDICATIONS OF TRANSCATHETER HEART VALVE INTERVENTIONS. JACC CARDIOVASCULAR INTERVENTION. DR.RAJAT GANDHI.
Twelve Months and Beyond: Long-Term Results of the Direct Flow Medical Repositionable and Retrievable Pericardial Valve for Percutaneous Aortic Valve Replacement.
| rejuveindiameditour.com.
Date of download: 9/19/2016 Copyright © The American College of Cardiology. All rights reserved. From: Percutaneous Aortic Valve Replacement Will Become.
VSD post TAVR: Mechanisms, Presentation and Management
Use of Postmarket Data to Support Premarket Approvals
Trans- catheter aortic valve replacement vs
How The Heart Works.
Anita W. Asgar MD, FRCPC, FACC Montreal Heart Institute
Design & Product Development Larry L Wood
Optimizing Valve Sizing: Role of CT vs. Echo
TAVR-Endocarditis Tarek Chami, MD
Blood Stasis on Transcatheter Valve Leaflets and Implications for Valve-in-Valve Leaflet Thrombosis  Koohyar Vahidkhah, PhD, Shahnaz Javani, MS, Mostafa.
Copyright © 2014 American Medical Association. All rights reserved.
Circulatory Diseases.
Optimizing Valve Sizing: Role of CT vs. Echo
5th Meeting on Acute Cardiac Care and Emergency Medicine, 2016 Vilnius
Chronic Cardiac Diseases To Drive Canada’s Prosthetic Heart Valves Market-Ken Research.
Is Open Heart Surgery Too Risky For You? Opt for a Minimally Invasive Procedure.
Transcatheter Aortic Valve Implantation: A Canadian Cardiovascular Society Position Statement  John Webb, MD, FRCPC, Josep Rodés-Cabau, MD, FRCPC, Stephen.
Transcatheter Aortic Valve Replacement
Nat. Rev. Cardiol. doi: /nrcardio
Early Results of Valve-Sparing Reimplantation Procedure Using the Valsalva Conduit: A Multicenter Study  Davide Pacini, MD, Fabrizio Settepani, MD, Ruggero.
Nat. Rev. Cardiol. doi: /nrcardio
A.A. Klein, S.T. Webb, S. Tsui, C. Sudarshan, L. Shapiro, C. Densem 
Five-Year Outcomes after Randomization to Transcatheter or Surgical Aortic Valve Replacement: Final Results of The PARTNER 1 Trial Michael J. Mack, MD.
Transapical Aortic Valve Implantation Without Angiography: Proof of Concept  Enrico Ferrari, MD, Christopher Sulzer, MD, Carlo Marcucci, MD, Elena Rizzo,
Blood Stasis on Transcatheter Valve Leaflets and Implications for Valve-in-Valve Leaflet Thrombosis  Koohyar Vahidkhah, PhD, Shahnaz Javani, MS, Mostafa.
FMRI vs. MRI By: Kathleen Shaffer.
The Heart and Blood Pressure
Circulatory system Quiz
Multimodality imaging of aortic stenosis.
Commentary: When a choice is not an echo
Novel treatment for critical aortic stenosis with severe aortic root calcification and coronary disease: Combined left internal thoracic artery graft.
Presentation transcript:

VIRTUAL SIMULATION OF TRANSCATHETER AORTIC VALVE IMPLANTATION Jenna Smetana and Jessica Sider, Swanson School of Engineering THE TAVI PROCEDURE IS FEASIBLE The use of finite element framework and virtual simulation is a breakthrough for the medical world, allowing the TAVI procedure to be conducted at optimal safety and efficiency, which is the ultimate goal of any risky operation. Through the use of these methods, patients have the ability to know exactly what is going to take place during their surgery and how their bodies are going to react. More than ever, TAVI is proving to be an effective alternative to open heart surgery, and the results support a positive outlook on the future of the treatment of aortic stenosis. This picture shows what is expected to happen when the implant is inserted into the aortic root in the case of these two patients. The different colors depict different levels of stress in certain areas. Simulations such as this help doctors to understand how different patients are going to be affected by the TAVI procedure. As the colors in the picture show, different types of patients will experience different complications. WHAT IS AORTIC STENOSIS? The aorta is the largest artery in the body and is the main valve that carries blood out of the heart, through the left ventricle, and to the rest of the body. In aortic stenosis, the aortic valve narrows, and blood flow from the heart is decreased. If the aortic valve does not open fully, the left ventricle is forced to work harder to pump blood out through the valve. This causes the muscles of the left ventricle walls to become thicker and the pressure in the heart will continuously rise. Severe aortic stenosis “can limit the amount of blood that reaches the brain and the rest of the body. When left untreated, as many as fifty percent of patients [suffering] will not survive more than an average of two years after the onset of symptoms. THE TAVI PROCEDURE Replacement of the aortic valve remains an effective treatment, but the complications from open-heart surgery decreased the interest and popularity of this method. The introduction of the TAVI procedure allowed the replacement of the aortic valve in a more successful, less complicated manner. Catheter-based aortic valve implantation has shown promising results in providing treatment options for patients with severe aortic stenosis who are poor open surgical candidates. There are two catheter-based aortic valves that have been used in human trials. The CoreValve and the Edwards Sapien valve have been implanted in the human body through the transapical placement through a direct apical puncture and the retrograde transfemoral approach through the femoral artery STEPS TO SIMULATING THE TAVI PROCEDURE HOW CAN TAVI BE IMPROVED? Safety, reliability, and efficacy are the key issues to address when promoting the TAVI procedure over traditional open-heart surgery. While its procedural risks differ from the original method, improvements for the design of the devices and implantation techniques are required to improve the success rate of TAVI, reduce hospital stay and rehabilitation, and decrease the rate of morbidity among high risk patients. The adopted computational framework to simulate the TAVI procedure can be divided into four main steps: processing of medical images, creation of analysis-suitable models, performance of all the required analyses to reproduce the entire clinical procedure, and post-processing of the simulation result and comparison with follow-up data. Medical imaging involves computed tomography data and 2D echo data. Analysis-suitable should include the aortic sinuses, native leaflets, calcifications, and the prosthetic device. Analysis of the process must include stent crimping, stent expansion, valve mapping, and valve closure. Post- processing will analyze the simulation output and follow-up data. The combination of these steps will provide physicians with a more accurate idea of how the specific patient will respond to the transcatheter aortic valve implantation procedure. STEP DESCRIPTION CREATION OF STENT MODEL CREATION OF THE AORTIC ROOT MODEL net of the stent created with Rhinoceros software v 4.0 geometry obtained from splines of STL file geometry is mirrored and replicated to unfold the geometry of the stent. 3D reconstruction of multi- detector computed tomography (MDCT) and magnetic resonance (MR) imaging of aortic root Two dimensional echocardiography PREPROCEDURAL COMPUTED TOMOGRAPHY provides clinicians with accurate view of whether patient can handle TAVI procedure detects dimensions of aortic root, degree of valve calcification, and morphology of access roots